About e lirag lutid e + m l
GLP-1 receptor agonist
Used for
- Weight management alongside reduced-calorie eating and increased physical activity.
- May reduce the risk of regaining weight after weight loss.
Usual adult dose
Start 0.6 mg under the skin daily; increase weekly to 3 mg daily.
Usual dose in children
For ages 12 and older with obesity: start 0.6 mg under the skin daily; increase weekly to 3 mg daily.
Common side effects
- Nausea, vomiting, diarrhea, constipation, or stomach pain
- Headache or dizziness
- Injection-site reactions
- Low blood sugar, especially with diabetes medicines
Important warnings
- Risk of pancreatitis, gallbladder problems, or dehydration-related kidney injury
- Do not use with personal or family history of medullary thyroid cancer or MEN2
- Not for use with other liraglutide products or other GLP-1 medicines
- Stop before planned pregnancy; seek urgent care for severe, persistent abdominal pain
Pregnancy
Do not use for weight loss during pregnancy; discontinue if pregnancy occurs.
Breastfeeding
Not recommended while breastfeeding because of limited safety information.
Interactions
- Insulin or sulfonylureas may increase low blood sugar risk
- May affect absorption of oral medicines by slowing stomach emptying
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.